Structural irregularities in MR corpus callosal images and their association with cerebrospinal fluid biomarkers in Mild Cognitive Impairments

被引:2
|
作者
Shaji, Sreelakshmi [1 ]
Palanisamy, Rohini [2 ]
Swaminathan, Ramakrishnan [1 ]
机构
[1] Indian Inst Technol Madras, Dept Appl Mech, Biomed Engn Grp, Noninvas Imaging & Diagnost Lab, Chennai, India
[2] Indian Inst Informat Technol Design & Mfg, Chennai, India
关键词
Early Mild Cognitive Impairment; Corpus Callosum; Structural irregularity; Fourier analysis; Cerebrospinal fluid markers; ALZHEIMERS-DISEASE; CSF BIOMARKERS;
D O I
10.1016/j.neulet.2023.137329
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In this study, irregularity measures from MR images of corpus callosal brain structures in healthy and Mild Cognitive Impairment (MCI) conditions are extracted and their association with Cerebrospinal Fluid (CSF) biomarkers are analyzed. For this, MR images of healthy controls, Early MCI (EMCI) and Late MCI (LMCI) subjects are considered from a public database. The considered images are preprocessed and corpus callosal structure is segmented. Structural irregularity measures are extracted from the segmented regions using Fourier analysis. Statistical tests are performed to identify the significant features which can characterize the MCI stages. Association of these measures with CSF amyloid beta and tau concentrations are further investigated. Results demonstrate that Fourier spectral analysis is able to characterize the non-periodic variations in the corpus callosal structures of healthy, EMCI and LMCI MR images. The callosal irregularity measures increase as the disease progresses from healthy to LMCI. Phosphorylated tau concentrations in CSF demonstrate a positive correlation with irregularity measures across the diagnostic groups. Significant association of callosal measures and amyloid beta levels are found to be absent in MCI stages. As corpus callosal structural irregularities due to early MCI condition and their association with CSF markers remain uncharacterized in the literature, this study seems to be clinically significant for the timely intervention of pre-symptomatic MCI stages.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment
    Araki, Wataru
    Kanemaru, Kazutomi
    Hattori, Kotaro
    Tsukamoto, Tadashi
    Saito, Yuko
    Yoshida, Sumiko
    Takano, Harumasa
    Sakata, Masuhiro
    Yokoi, Yuma
    Omachi, Yoshie
    Nagaoka, Utako
    Nagao, Masahiro
    Komori, Takashi
    Tachimori, Hisateru
    Murayama, Shigeo
    Mizusawa, Hidehiro
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (02) : 341 - 347
  • [42] Obstructive sleep apnea and Alzheimer's disease-related cerebrospinal fluid biomarkers in mild cognitive impairment
    Diaz-Roman, Monica
    Pulopulos, Matias M.
    Baquero, Miguel
    Salvador, Alicia
    Cuevas, Ana
    Ferrer, Ines
    Ciopat, Oana
    Gomez, Enriqueta
    SLEEP, 2021, 44 (01)
  • [43] Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment
    Kern, Silke
    Syrjanen, Jeremy A.
    Blennow, Kaj
    Zetterberg, Henrik
    Skoog, Ingmar
    Waern, Margda
    Hagen, Clinton E.
    van Harten, Argonde C.
    Knopman, David S.
    Jack, Clifford R., Jr.
    Petersen, Ronald C.
    Mielke, Michelle M.
    JAMA NEUROLOGY, 2019, 76 (02) : 187 - 193
  • [44] Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment
    Trammell, Antoine R.
    McDaniel, Darius J.
    Obideen, Malik
    Okafor, Maureen
    Thomas, Tiffany L.
    Goldstein, Felicia C.
    Shaw, Leslie M.
    Hajjar, Ihab M.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 77 (02) : 843 - 853
  • [45] Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review
    Sagues-Sese, Elena
    Rioja, Jose
    Garzon-Maldonado, Francisco J.
    Narvaez, Manuel
    Garcia-Arnes, Juan A.
    Garcia-Casares, Natalia
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 90 (01) : 1 - 13
  • [46] Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis
    Eppig, Joel S.
    Edmonds, Emily C.
    Campbell, Laura
    Sanderson-Cimino, Mark
    Delano-Wood, Lisa
    Bondi, Mark W.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2017, 23 (07) : 564 - 576
  • [47] Role of quantitative MRI measures in prognostic assessment of Mild Cognitive Impairment patients and correlation with Cerebrospinal Fluid biomarkers
    Machado, R.
    Baldeiras, I.
    Cunha, G.
    Morais, R.
    Lemos, R.
    Caetano, G.
    Castelo-Branco, M.
    Santana, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 96 - 96
  • [48] Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment
    Wataru Araki
    Kazutomi Kanemaru
    Kotaro Hattori
    Tadashi Tsukamoto
    Yuko Saito
    Sumiko Yoshida
    Harumasa Takano
    Masuhiro Sakata
    Yuma Yokoi
    Yoshie Omachi
    Utako Nagaoka
    Masahiro Nagao
    Takashi Komori
    Hisateru Tachimori
    Shigeo Murayama
    Hidehiro Mizusawa
    Aging Clinical and Experimental Research, 2022, 34 : 341 - 347
  • [49] The Head Turning Sign in Dementia and Mild Cognitive Impairment: Its Relationship to Cognition, Behavior, and Cerebrospinal Fluid Biomarkers
    Duraes, Joao
    Tabuas-Pereira, Miguel
    Araujo, Rui
    Duro, Diana
    Baldeiras, Ines
    Santiago, Beatriz
    Santana, Isabel
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2018, 46 (1-2) : 42 - 49
  • [50] Associations Between Free and Cued Selective Reminding Test and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment
    Giuffre, Guido Maria
    Quaranta, Davide
    Citro, Salvatore
    Morganti, Tommaso Giuseppe
    Martellacci, Noemi
    Vita, Maria Gabriella
    Rossini, Paolo Maria
    Calabresi, Paolo
    Marra, Camillo
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 100 (02) : 713 - 723